Entospletinib Monotherapy and in Combination With Chemotherapy in Adults With Acute Myeloid Leukemia (AML)
Clinical trial NCT02343939 · TERMINATED
Trial details
- NCT number
- NCT02343939
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2018-09-04
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.